Hartmann B - Search Results

1

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.

Umapathysivam MM, Araldi E, Hastoy B, Dawed AY, Vatandaslar H, Sengupta S, Kaufmann A, Thomsen S, Hartmann B, Jonsson AE, Kabakci H, Thaman S, Grarup N, Have CT, Færch K, Gjesing AP, Nawaz S, Cheeseman J, Neville MJ, Pedersen O, Walker M, Jennison C, Hattersley AT, Hansen T, Karpe F, Holst JJ, Jones AG, Ristow M, McCarthy MI, Pearson ER, Stoffel M, Gloyn AL. Umapathysivam MM, et al. Among authors: hartmann b. medRxiv [Preprint]. 2023 Apr 12:2023.04.07.23288197. doi: 10.1101/2023.04.07.23288197. medRxiv. 2023. PMID: 37090505 Free PMC article. Preprint.

2

Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

Hartmann B, Thulesen J, Hare KJ, Kissow H, Orskov C, Poulsen SS, Holst JJ. Hartmann B, et al. Regul Pept. 2002 May 30;105(3):173-9. doi: 10.1016/s0167-0115(02)00013-7. Regul Pept. 2002. PMID: 11959371

3

Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development.

Petersen YM, Hartmann B, Holst JJ, Le Huerou-Luron I, Bjørnvad CR, Sangild PT. Petersen YM, et al. Among authors: hartmann b. J Nutr. 2003 Jun;133(6):1781-6. doi: 10.1093/jn/133.6.1781. J Nutr. 2003. PMID: 12771317

4

Somatostatin receptors.

Møller LN, Stidsen CE, Hartmann B, Holst JJ. Møller LN, et al. Among authors: hartmann b. Biochim Biophys Acta. 2003 Sep 22;1616(1):1-84. doi: 10.1016/s0005-2736(03)00235-9. Biochim Biophys Acta. 2003. PMID: 14507421 Free article. Review.

5

Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.

Hansen L, Hartmann B, Mineo H, Holst JJ. Hansen L, et al. Among authors: hartmann b. Regul Pept. 2004 Apr 15;118(1-2):11-8. doi: 10.1016/j.regpep.2003.10.021. Regul Pept. 2004. PMID: 14759551

6

Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IV.

Hansen L, Hare KJ, Hartmann B, Deacon CF, Ugleholdt RK, Plamboeck A, Holst JJ. Hansen L, et al. Among authors: hartmann b. Regul Pept. 2007 Feb 1;138(2-3):126-32. doi: 10.1016/j.regpep.2006.08.012. Epub 2006 Nov 14. Regul Pept. 2007. PMID: 17107718

7

Glucagon-like peptide-2 in umbilical cord blood from mature infants.

Bodé S, Hartmann B, Holst JJ, Greisen G. Bodé S, et al. Among authors: hartmann b. Neonatology. 2007;91(1):49-53. doi: 10.1159/000096971. Epub 2006 Nov 10. Neonatology. 2007. PMID: 17344652

8

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats.

Simonsen L, Pilgaard S, Orskov C, Rosenkilde MM, Hartmann B, Holst JJ, Deacon CF. Simonsen L, et al. Among authors: hartmann b. Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G288-95. doi: 10.1152/ajpgi.00453.2006. Epub 2007 Apr 12. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17431213 Free article.

9

Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.

Holst JJ, Hartmann B, Gottschalck IB, Jeppesen PB, Miholic J, Henriksen DB. Holst JJ, et al. Among authors: hartmann b. Scand J Gastroenterol. 2007 Jul;42(7):814-20. doi: 10.1080/00365520601137272. Scand J Gastroenterol. 2007. PMID: 17558904

10

The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.

Hare KJ, Hartmann B, Kissow H, Holst JJ, Poulsen SS. Hare KJ, et al. Among authors: hartmann b. Clin Cancer Res. 2007 Sep 1;13(17):5170-5. doi: 10.1158/1078-0432.CCR-07-0574. Clin Cancer Res. 2007. PMID: 17785573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

930 results

Search Page